Muhammad Rahman Efendi Nasution

Quick facts

Phase 3 pipeline

• Non Opioid Analgesics · Pain Management
  Non-opioid analgesics reduce pain by inhibiting cyclooxygenase enzymes or other pain signaling pathways without activating opioid receptors.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Muhammad Rahman Efendi Nasution portfolio CI brief
• Muhammad Rahman Efendi Nasution pipeline updates RSS